Fig. 2From: Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practiceStandard-of-care treatments and combination therapy involving ADCs in lung cancer. ADC antibody‒drug conjugate, VEGFR vascular endothelial growth factor receptorBack to article page